Regulatory AI · Product

MedNova IND gap assessment

A source-traced IND gap assessment platform that finds missing and inconsistent content before submission, with an expert reviewing findings.

Live demonstration (demo data)
Client
Amia product, used with biotech teams
Industry
Life Sciences
Services
Document Intelligence, AI Governance, Security & Evaluation
Technology
LLM reasoning, Retrieval, Rules engine, Human review, Audit logging

The challenge

An IND is assembled from many documents written by different people. Gaps and inconsistencies tend to surface late, when they are expensive to fix. Teams needed a second reader that applies the same rules every time and shows its evidence.

What we built

A rules engine for deterministic checks kept separate from AI reasoning, retrieval over the sponsor’s documents and public regulatory sources, and findings ranked by severity with the evidence attached. In our service, a regulatory expert reviews findings before they reach the client.

Key capabilities

Inside the solution.

Deterministic checks

Rule checks kept separate from AI reasoning so results are repeatable.

Severity-ranked findings

Critical, major and minor findings with evidence attached.

Source tracing

Findings link back to the source passage.

Expert in the loop

A regulatory expert reviews findings in our service.

Outcome

A CEO of a San Diego-based clinical-stage biotechnology company reported that the analysis surfaced critical gaps and missing elements their regulatory writers had overlooked.

“Amia’s MedNova IND gap analysis identified several critical gaps and missing elements that our regulatory writers had overlooked.”

Chief Executive Officer, San Diego-based clinical-stage biotechnology company

Screens use a hypothetical IND with demo data. Not a substitute for regulatory review.

Start a conversation

Have a workflow that AI should handle?

Tell us what you are working on. We will reply with questions or a proposed scope, and we are happy to sign an NDA first.